4593-20-8 Usage
General Description
1-(Chloroacetyl)-4-methylpiperidine is a chemical compound with the molecular formula C9H16ClNO. It is a piperidine derivative that contains a chloroacetyl group and a methyl group attached to the piperidine ring. 1-(CHLOROACETYL)-4-METHYLPIPERIDINE has applications in the pharmaceutical industry, where it is used as an intermediate in the synthesis of various drugs and pharmacologically active compounds. It is also used as a reagent in organic chemistry for the preparation of other organic compounds. 1-(Chloroacetyl)-4-methylpiperidine is considered to be a potentially hazardous chemical and should be handled and used with caution in a laboratory or industrial setting.
Check Digit Verification of cas no
The CAS Registry Mumber 4593-20-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,9 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4593-20:
(6*4)+(5*5)+(4*9)+(3*3)+(2*2)+(1*0)=98
98 % 10 = 8
So 4593-20-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H14ClNO/c1-7-2-4-10(5-3-7)8(11)6-9/h7H,2-6H2,1H3
4593-20-8Relevant articles and documents
Curcumol derivatives with anti-tumor activity, and preparation method and application of curcumol derivatives
-
Paragraph 0035; 0036; 0037; 0039, (2017/08/29)
The invention relates to curcumol derivatives with anti-tumor activity, and a preparation method and application of the curcumol derivatives, belonging to the technical field of medicines. The invention relates to new compounds which have the anti-tumor a
COMPOUNDS HAVING ACTIVITY AT 5HT2C RECEPTOR AND USES THEREOF
-
Page 15-16, (2010/02/08)
Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein Q is phenyl or a 6-membered heteroaromatic group containing at least one nitrogen atom; A is -(CH2-CH2)-, -(CH=CH)-, -(CH2)
COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY
-
Page/Page column 30, (2008/06/13)
Compounds of formula (I) or a pharmaceutically acceptable salt thereof are disclosed: wherein R1 is hydrogen, hydroxy, fluoro, chloro, C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkyloxy, C1-6alkoxy or haloC